Use of retroviral markers to identify efficacy of purging and origin of relapse following autologous bone marrow and peripheral blood cell transplantation in indolent B cell neoplasms (follicular non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL) patients).
D001483:Base Sequence; D001804:Blood Transfusion, Autologous; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation; D002985:Clinical Protocols; D017931:DNA Primers; D005819:Genetic Markers; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000628:therapy*; D008969:Molecular Sequence Data; D009364:Neoplasm Recurrence, Local; D012190:Retroviridae / Q000235:genetics; D014182:Transplantation, Autologous
D017931:DNA Primers; D005819:Genetic Markers